当前位置:首页 - 行情中心 - 葵花药业(002737) - 财务分析 - 现金流量表

葵花药业

(002737)

  

流通市值:77.73亿  总市值:77.73亿
流通股本:5.84亿   总股本:5.84亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金846,012,773.563,088,389,815.961,558,594,617.291,414,883,507.64
  收到其他与经营活动有关的现金13,581,283.77158,909,945.72128,347,590.4889,936,111.63
  经营活动现金流入小计859,594,057.333,247,299,761.681,686,942,207.771,504,819,619.27
  购买商品、接受劳务支付的现金255,078,756.68842,071,176.85420,794,433.08303,416,496.29
  支付给职工以及为职工支付的现金145,994,897.4563,392,758.43440,849,607.04306,103,795.97
  支付的各项税费89,216,013.33232,575,591.01171,412,976.09121,141,337.08
  支付其他与经营活动有关的现金291,197,550.021,034,294,625.04433,561,199.36424,535,605.51
  经营活动现金流出小计781,487,217.432,672,334,151.331,466,618,215.571,155,197,234.85
  经营活动产生的现金流量净额78,106,839.9574,965,610.35220,323,992.2349,622,384.42
二、投资活动产生的现金流量:
  收回投资收到的现金2,358,414,0159,317,544,0118,119,116,312.915,617,543,011
  取得投资收益收到的现金11,469,388.6135,480,586.7631,198,234.4419,865,775.23
  处置固定资产、无形资产和其他长期资产收回的现金净额40,000524,714191,87627,168
  投资活动现金流入小计2,369,923,403.619,353,549,311.768,150,506,423.355,637,435,954.23
  购建固定资产、无形资产和其他长期资产支付的现金27,209,732.2396,103,588.2167,421,423.121,388,737.01
  投资支付的现金1,800,000,0009,810,001,0008,360,000,0005,560,000,000
  支付其他与投资活动有关的现金-62,937.89--
  投资活动现金流出小计1,827,209,732.239,906,167,526.18,427,421,423.15,581,388,737.01
  投资活动产生的现金流量净额542,713,671.38-552,618,214.34-276,914,999.7556,047,217.22
三、筹资活动产生的现金流量:
  取得借款收到的现金-118,000,00018,000,000-
  筹资活动现金流入平衡项目-00-
  筹资活动现金流入小计-118,000,00018,000,000-
  偿还债务支付的现金-13,000,000--
  分配股利、利润或偿付利息支付的现金603,750311,071,734.72310,506,399.09-
  其中:子公司支付给少数股东的股利、利润-18,947,768.0518,947,768.05-
  支付其他与筹资活动有关的现金1,783,556.124,122,924.063,501,536.722,268,340.77
  筹资活动现金流出小计2,387,306.12328,194,658.78314,007,935.812,268,340.77
  筹资活动产生的现金流量净额-2,387,306.12-210,194,658.78-296,007,935.81-2,268,340.77
四、汇率变动对现金及现金等价物的影响-175,358.63-193,176.6665,213.33137,250.34
五、现金及现金等价物净增加额618,257,846.53-188,040,439.43-352,533,730.03403,538,511.21
  加:期初现金及现金等价物余额849,920,259.081,037,960,698.511,037,960,698.511,037,960,698.51
  期末现金及现金等价物余额1,468,178,105.61849,920,259.08685,426,968.481,441,499,209.72
补充资料:
  净利润--297,073,301.51-81,569,934.45
  资产减值准备-77,428,515.19-7,523,637.63
  固定资产和投资性房地产折旧-141,708,886.19-71,317,619.15
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-141,708,886.19-71,317,619.15
  无形资产摊销-26,615,432.56-13,057,358.11
  长期待摊费用摊销-4,434,304.92-2,157,363
  处置固定资产、无形资产和其他长期资产的损失-654,459.15-653,722.6
  固定资产报废损失-1,191,497.68--
  公允价值变动损失--3,891,722.08--5,812,389.88
  财务费用-4,001,177.6-794,028.38
  投资损失--31,048,755.67--10,371,400.62
  递延所得税--28,463,731.21--280,047.2
  其中:递延所得税资产减少--26,523,568.09-747,793.51
    递延所得税负债增加--1,940,163.12--1,027,840.71
  存货的减少-229,946,642.24-119,542,113.73
  经营性应收项目的减少-421,485,281.38-246,443,621.92
  经营性应付项目的增加-23,144,120.09--179,116,141.61
  现金的期末余额-849,920,259.08-1,441,499,209.72
  减:现金的期初余额-1,037,960,698.51-1,037,960,698.51
  现金及现金等价物的净增加额--188,040,439.43-403,538,511.21
公告日期2026-04-302026-04-272025-10-282025-08-28
审计意见(境内)标准无保留意见
TOP↑